Q BioMed Inc.
QBIO · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Revenue | $284 | $196 | $30 | $0 |
| % Growth | 45.4% | 552% | – | – |
| Cost of Goods Sold | $293 | $247 | $326 | $50 |
| Gross Profit | -$9 | -$51 | -$296 | -$50 |
| % Margin | -3.2% | -26.2% | -986.7% | – |
| R&D Expenses | $125 | $1,074 | $1,880 | $3,539 |
| G&A Expenses | $3,281 | $6,263 | $10,969 | $4,481 |
| SG&A Expenses | $3,311 | $6,263 | $10,969 | $4,481 |
| Sales & Mktg Exp. | $30 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,437 | $7,337 | $12,849 | $8,020 |
| Operating Income | -$3,446 | -$7,389 | -$13,145 | -$8,020 |
| % Margin | -1,211.7% | -3,777.4% | -43,818% | – |
| Other Income/Exp. Net | $1,394 | -$852 | -$347 | -$2,260 |
| Pre-Tax Income | -$2,052 | -$8,241 | -$13,492 | -$10,280 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,052 | -$8,241 | -$13,492 | -$10,280 |
| % Margin | -721.7% | -4,213% | -44,974% | – |
| EPS | -0.078 | -0.33 | -0.65 | -0.78 |
| % Growth | 76.3% | 49.2% | 16.7% | – |
| EPS Diluted | -0.078 | -0.33 | -0.65 | -0.78 |
| Weighted Avg Shares Out | 44,757 | 26,779 | 22,160 | 15,041 |
| Weighted Avg Shares Out Dil | 44,757 | 26,779 | 22,160 | 15,041 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1,460 |
| Interest Expense | $1,384 | $507 | $296 | $1,460 |
| Depreciation & Amortization | $50 | $50 | $50 | $50 |
| EBITDA | -$618 | -$7,684 | -$13,146 | -$7,970 |
| % Margin | -217.2% | -3,928.3% | -43,819.9% | – |